This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Texas System, Xoma Corporation, Baxter Healthcare Sa. Active years: 1999-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dallas, TX (US) (1999 - 2008)
- Vienna, VA (US) (2014)
Company Filing History:
2 out of 5,638 
2 out of 142 
1 out of 1,201 
Years Active: 1999-2014
Title: Brett P Giroir: Innovator in Cardiovascular Treatment
Introduction
Brett P Giroir is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of cardiovascular treatment. With a total of 8 patents, he has developed innovative methods and pharmaceutical compositions aimed at improving cardiac function and assessing cardiovascular risk.
Latest Patents
Giroir's latest patents include a method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as a cardiac-derived myocardial depressant factor. One embodiment of this invention relates to a pharmaceutical composition that includes a therapeutically effective amount of at least one anti-MIF antibody and at least one pharmaceutically acceptable carrier. Another embodiment involves a pharmaceutical composition that includes a therapeutically effective amount of at least one anti-CD74 antibody and at least one pharmaceutically acceptable carrier. Additionally, he has developed a composition that combines a therapeutically effective amount of at least one anti-TNFR antibody, at least one anti-MIF antibody, and at least one pharmaceutically acceptable carrier. These inventions aim to treat or prevent cardiac dysfunction, improve cardiac function following acute myocardial infarction, and identify MIF inhibitors. Furthermore, he has explored the use of macrophage migration inhibitory factor as a marker for cardiovascular risk, providing methods for risk assessment and treatment based on MIF concentration in the blood.
Career Highlights
Throughout his career, Brett P Giroir has worked with various institutions, including the University of Texas System. His innovative work has positioned him as a key figure in the development of new therapeutic strategies for cardiovascular health.
Collaborations
Giroir has collaborated with notable professionals in his field, including Patrick J Scannon and Monty S Willis, contributing to the advancement of cardiovascular research and treatment methodologies.
Conclusion
Brett P Giroir's contributions to cardiovascular treatment through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for innovative solutions to improve cardiac health and assess cardiovascular risk effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile